Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 14, 11:16
395.35
9.05 (2.34%)
VOLUME 92,891
LIVE
NSE
Oct 14, 11:17
395.50
9.2 (2.38%)
VOLUME 1,848,540
Announcements on Sun Pharma

14th-Oct-2019 09:32Source: NSE

Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 14, 2019, titled "Launch of CEQUA for the Treatment of Dry Eye Disease in the US".

12th-Oct-2019 17:59Source: BSE

Sun Pharmaceutical Industries- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find enclosed, intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12th-Oct-2019 14:58Source: BSE

Sun Pharmaceutical Industries- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 12, 2019 for Shanghvi Finance Pvt Ltd

9th-Oct-2019 23:11Source: BSE

Sun Pharmaceutical Industries- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release relating to the presentation of long-term follow-up data fo ILUMYA at the 28th European Academy of Dermatology and Venereology Congress (EADV) in Madrid, Spain.,

9th-Oct-2019 16:14Source: BSE

Sun Pharmaceutical Industries- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 09, 2019 for Shanghvi Finance Pvt Ltd

1st-Oct-2019 13:23Source: NSE

Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

17th-Sep-2019 13:08Source: BSE

Sun Pharmaceutical Industries- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find enclosed intimation under regulation 39(3)

12th-Sep-2019 16:49Source: BSE

Sun Pharmaceutical Industries- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanghvi Finance Pvt Ltd

9th-Sep-2019 09:11Source: BSE

Sun Pharmaceutical Industries- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditya Medisales Ltd

1 2 3 4 5 Next >>
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.